会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Burner
    • 刻录机
    • US4451228A
    • 1984-05-29
    • US379879
    • 1982-05-19
    • Chuzoh WadaYoshikazu MatsudaYoshio Asano
    • Chuzoh WadaYoshikazu MatsudaYoshio Asano
    • F23D3/26F23N5/00
    • F23D3/26
    • A burner of wick type is disclosed which secures user safety by stopping combustion through an oxygen depletion protection function in the event of an oxygen depletion. When tar is accumulated in the wick, the wick is burnt to clean the tar with the liquid fuel supply cut off, thus burning out the liquid fuel contained in the wick. In the process, the combustion temporarily becomes unstable and a great amount of carbon monoxide is generated, resulting in a state similar to oxygen depletion. In a burner with an oxygen depletion protection function, the combustion is stopped during the wick cleaning, with the result that most of the tar accumulated in the wick remains unburnt, adversely affecting both the fuel absorption characteristic and service life of the wick. This invention is such that the oxygen depletion protection function is not operated during the wick cleaning. The tar accumulated in the wick is mostly burnt out and thus the deterioration of the fuel absorption characteristic is prevented thereby improving the service life of the wick.
    • 公开了一种灯芯型燃烧器,其通过在氧耗尽的情况下通过氧耗尽保护功能停止燃烧来确保用户的安全性。 当焦油积聚在灯芯中时,燃油芯被燃烧以清除焦油,液体燃料供应被切断,从而燃烧芯中所含的液体燃料。 在该过程中,燃烧暂时变得不稳定并且产生大量的一氧化碳,导致类似于氧耗尽的状态。 在具有氧气消耗保护功能的燃烧器中,在芯吸清洁期间燃烧停止,结果是积聚在油芯中的大部分焦油保持不燃,不利地影响油缸的燃料吸收特性和使用寿命。 本发明使得在芯吸清洁期间不运行氧耗尽保护功能。 芯中累积的焦油大部分被烧掉,因此能够防止燃料吸收特性的劣化,从而提高了油绳的使用寿命。
    • 5. 发明授权
    • LED display device and method for controlling the same
    • LED显示装置及其控制方法
    • US6144352A
    • 2000-11-07
    • US80012
    • 1998-05-15
    • Yoshikazu MatsudaKazuya Yamaguchi
    • Yoshikazu MatsudaKazuya Yamaguchi
    • G09G3/20G09G5/02H04N9/30G09G3/32
    • H04N9/30G09G3/32G09G5/02G09G2300/0452
    • An LED display device includes an LED display section including a plurality of light emitting blocks arranged in a matrix, each light emitting block including at least a red LED, a green LED, and a blue LED; a color control section including a red color control circuit, a green color control circuit and a blue color control circuit, for controlling an amount of light emitted by the red LED, the green LED, and the blue LED in accordance with a red color signal, a green color signal and a blue color signal; and an LED driving control section including a red LED driving circuit, a green LED driving circuit and a blue LED driving circuit, for controlling the LED display section in response to an output signal from the color control section. At least one of a control of controlling the red LED driving circuit and the green LED driving circuit in response to an output signal from the red color control circuit and a control of controlling the green LED driving circuit and the red LED driving circuit in response to an output signal from the green color control circuit is performed.
    • LED显示装置包括:LED显示部,包括以矩阵状排列的多个发光块,每个发光块至少包括红色LED,绿色LED和蓝色LED; 颜色控制部分,包括红色控制电路,绿色控制电路和蓝色控制电路,用于根据红色信号控制红色LED,绿色LED和蓝色LED发出的光量 ,绿色信号和蓝色信号; 以及包括红色LED驱动电路,绿色LED驱动电路和蓝色LED驱动电路的LED驱动控制部分,用于响应于来自颜色控制部分的输出信号来控制LED显示部分。 响应于来自红色控制电路的输出信号控制红色LED驱动电路和绿色LED驱动电路的控制中的至少一个,以及响应于控制绿色LED驱动电路和红色LED驱动电路的控制 执行来自绿色控制电路的输出信号。
    • 6. 发明授权
    • Purine derivatives and medicinal use thereof
    • 嘌呤衍生物及其药用
    • US06310070B1
    • 2001-10-30
    • US09462861
    • 2000-04-28
    • Akihisa YokoyamaSumitsugu KisanukiYoshikazu MatsudaJunko MatsuiYoshiaki Isobe
    • Akihisa YokoyamaSumitsugu KisanukiYoshikazu MatsudaJunko MatsuiYoshiaki Isobe
    • C07D47330
    • C07D473/30
    • A novel purine derivative exhibiting an effect to control inflammatory symptoms characteristic to nephritis and a medicine comprising this compound as an effective ingredient are provided. The compound is represented by the following general formula (I), wherein R1 is a hydrocarbon group having 17 or less carbon atoms and R2 is a hydrocarbon group having 16 or less carbon atoms, wherein one or more CH2 g roups in the hydrocarbon group which 7013 do not directly bind with the carbon atom at 2 or 7 position of the purine ring replaced are by carbonyl groups, sulfonyl groups, O, or S and/or one or more CH groups in the hydrocarbon group which do not directly bind with the carbon atom at 2 or 7 position of the purine ring are replaced by N, C-halogen, or C—C≡N, or a pharmaceutically acceptable salt thereof.
    • 本发明提供了具有控制肾炎特征性炎症症状的效果的新型嘌呤衍生物和含有该化合物作为有效成分的药物。 该化合物由以下通式(I)表示,其中R 1是具有17个或更少碳原子的烃基,R 2是具有16个或更少碳原子的烃基,其中一个或多个在烃基中的CH 2 7013不与嘌呤环的2或7位的碳原子直接结合,所取代的碳原子是羰基,磺酰基,O或S和/或烃基中一个或多个不与直接键合的CH基团 嘌呤环2或7位的碳原子被N,C-卤素或CC = N取代,或其药学上可接受的盐。